Solana Company

NASDAQ:HSDT

Medical - Devices

Healthcare
$1.63 +0.63%

+$0.01 today

Market cap
$95.17M
Beta
1.03
P/E (TTM)
-0.9
EPS (TTM)
-$1.78
52W Low $1.19High $25.50

Volume 0.23M

Average 0.38M

HSDT Revenue

Total income from selling goods and services before any costs are deducted; the top line of the income statement.

Solana CompanyNASDAQ: HSDT

Revenue · Q1 FY2026 · quarter ended Mar 2026

Revenue growth accelerates

Q1 FY2026 revenue of $3.62M rose 7289.8% year over year, ahead of the +2109.4% change in trailing-twelve-month revenue. Sequentially, it fell 30.7% from the prior quarter. Over 3 fiscal years it compounded at +97.0% a year.

Context

  • Revenue increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether revenue reaches the consensus estimate from 1 analysts of $12.35M (+105.3%) for the fiscal year ending Dec 2026, a slowdown from the +1057.1% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
$3.62M-30.7% QoQ
Last fiscal yearDec 2025
$6.02M+1057.1% YoY
LTMMar 2026
$9.59M+2109.4% YoY
Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7289.8%+8039.5%+749.7 pp
1 year+1057.1%+105.3%-951.9 pp
3-year CAGR+97.0%+25.5%-71.5 pp
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Revenue history

USD · from the income statement

Latest · FY2025
6.02M USD
Year-over-year change
+1057.1%
4-year CAGR
+84.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Revenue vs competitors

How HSDT compares with its peers on the latest reported figures

  • HSDT's LTM Mar 2026 revenue of $9.59M is the 10th highest of the 11 companies compared; the peer median is $58.32M.
  • Its year-over-year change of +2109.4% is the highest of 11, against a peer median of +11.8%.
  • Over three fiscal years its annual growth of +97.0% compares with a peer median of +12.2%.
HSDT Competitors Peer median
Revenue for HSDT and competitors
Company Period LTM YoY 3-year CAGR
INGNInogen, Inc.LTM Mar 2026$351.5M +3.4%-2.6%
QTRXQuanterix CorporationLTM Mar 2026$144.87M +8.2%+9.5%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$142.4M +3.5%+9.3%
OMOutset Medical, Inc.LTM Mar 2026$117.59M +2.0%+1.2%
ELMDElectromed, Inc.LTM Mar 2026$71.75M +16.8%+15.4%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$44.88M +39.6%+53.9%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$44.33M +22.5%+38.1%
PROFProfound Medical Corp.LTM Mar 2026$18.87M +34.8%+34.8%
NNOXNano-X Imaging Ltd.LTM Dec 2025$13.02M +15.4%+14.9%
HSDTSolana CompanyLTM Mar 2026$9.59M +2109.4%+97.0%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$618K -58.0%-50.1%
Peer median (excluding HSDT) $58.32M+11.8%+12.2%

Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue522K787K644K520K6.02M
Cost of Revenue298K463K583K582K500K
Gross Profit224K324K61K(62K)5.52M
Gross Margin42.9%41.2%9.5%-11.9%91.7%
Research & Development5.99M4.26M2.94M3.66M3.51M
Selling, General & Admin12.18M10.64M9.27M10.12M23.13M
Operating Expenses18.37M15.84M12.49M13.84M26.64M
Depreciation & Amortization312K255K162K60K680K
EBITDA(17.82M)(14.5M)(12.11M)(13.8M)(39.58M)
EBITDA Margin-3413.8%-1842.9%-1880.0%-2654.4%-657.7%
Operating Income(18.14M)(15.52M)(12.43M)(13.9M)(21.12M)
Operating Margin-3475.5%-1971.5%-1929.8%-2673.7%-351.0%
Interest Income00257K00
Interest Expense0834K017K635K
Other Income / Expenses10K1.44M3.58M2.16M(19.77M)
Income Before Tax(18.13M)(14.07M)(8.85M)(11.74M)(40.89M)
Pre-Tax Margin-3473.6%-1788.1%-1374.2%-2258.1%-679.6%
Income Tax Expense00000
Net Income(18.13M)(14.07M)(8.85M)(11.74M)(40.89M)
Net Margin-3473.6%-1788.1%-1374.2%-2258.1%-679.6%
EPS (Basic)(184.51)(26.06)(7.28)(4.33)(1.85)
EPS (Diluted)(184.51)(26.06)(7.28)(4.33)(1.85)
Weighted Avg Shares98.27K539.89K1.22M2.71M22.05M
Weighted Avg Shares (Diluted)98.27K539.89K1.22M2.71M22.05M

Solana Company

NASDAQ:HSDT

Intrinsic Alpha fair value

Locked

Current Price

$1.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.